title: The pathogenesis of malaria: a new perspective.
abstract: With 3·3 billion people at risk of infection, malaria remains one of the world's most significant health problems. Increasing resistance of the main causative parasite to currently available drugs has created an urgent need to elucidate the pathogenesis of the disease in order to develop new treatments. A possible clue to such an understanding is that the malaria parasite Plasmodium falciparum selectively absorbs vitamin A from the host and appears to use it for its metabolism; serum vitamin A levels are also reduced in children with malaria. Although vitamin A is essential in low concentration for numerous biological functions, higher concentrations are cytotoxic and pro-oxidant, and potentially toxic quantities of the vitamin are stored in the liver. During their life cycle in the host the parasites remain in the liver for several days before invading the red blood cells (RBCs). The hypothesis proposed is that the parasites emerge from the liver packed with vitamin A and use retinoic acid (RA), the main biologically active metabolite of vitamin A, as a cell membrane destabilizer to invade the RBCs throughout the body. The characteristic hemolysis and anemia of malaria and other symptoms of the disease may thus be manifestations of an endogenous form of vitamin A intoxication associated with high concentrations of RA but low concentrations of retinol (ROL). Retinoic acid released from the parasites may also affect the fetus and cause preterm birth and fetal growth restriction (FGR) as a function of the membranolytic and growth inhibitory effects of these compounds, respectively. Subject to testing, the hypothesis suggests that parasite vitamin A metabolism could become a new target for the treatment and prevention of malaria.
authors.affiliation: Jackson State University, USA. amawsn@gmail.com
authors.forename: Anthony R
authors.initials: AR
authors.lastname: Mawson
mesh_terms: D000740:Anemia / Q000209:etiology; D004705:Endocytosis; D004912:Erythrocytes / Q000469:parasitology*; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008099:Liver / Q000469:parasitology; D016778:Malaria, Falciparum / Q000469:parasitology* / Q000473:pathology; D010963:Plasmodium falciparum / Q000502:physiology*; D014212:Tretinoin / Q000378:metabolism; D014801:Vitamin A / Q000378:metabolism
chemical_list: D014801:Vitamin A; D014212:Tretinoin